Max Robotics — Global Service Robot Directory + US Certification

About

A leading figure in Asian urologic oncology, Jun Miyazaki has dedicated his career to understanding and improving prostate cancer outcomes across the continent. His work is central to the Asian Prostate Cancer (A-CaP) study, a landmark, Asia-wide initiative he helped launch in 2015. This collaborative project, detailed in his highly influential 2018 report, aims to systematically survey treatment patterns and patient outcomes following a histopathological diagnosis of prostate cancer. By clarifying the distinct epidemiological and clinical distributions of the disease in Asian populations, Miyazaki’s research provides critical insights that challenge Western-centric models. His contributions are vital for tailoring effective screening and treatment strategies for the region, addressing a major gap in global oncology. With over 12 citations on this foundational work alone, his impact is evident in shaping a new, data-driven understanding of prostate cancer in Asia, making him a key architect of collaborative, region-specific cancer research.